MAI Capital Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
MAI Capital Management's DFTX Position: Q3 2026 in Review
MAI Capital Management sold out of Definium Therapeutics (DFTX) in Q3 2026, closing a stake of 5,686 shares — an estimated $267K sold.
MAI Capital Management first reported a position in DFTX in Q4 2021 and held it in 9 quarters. The position peaked at $267K in Q2 2026. 349 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- MAI Capital Management reported no remaining Definium Therapeutics position as of Q3 2026 after selling out during the quarter.
- MAI Capital Management sold 5,686 Definium Therapeutics shares in Q3 2026, an estimated $267K.
- MAI Capital Management first reported a position in Definium Therapeutics in Q4 2021 and held it in 9 quarters.
- MAI Capital Management's Definium Therapeutics position peaked at $267K in Q2 2026.
- 349 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on MAI Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.